(Q37907198)

25 August 2017

1 reference

title

Lessons from probiotic-host interaction studies in murine models of experimental colitis (English)

1 reference

25 August 2017

0 references

1 reference

Ingmar J J Claes

1

1 reference

25 August 2017

Sigrid C J De Keersmaecker

series ordinal

2

1 reference

25 August 2017

Jos Vanderleyden

series ordinal

3

1 reference

25 August 2017

Sarah Lebeer

series ordinal

4

1 reference

25 August 2017

publication date

28 July 2011

1 reference

Molecular Nutrition and Food Research

25 August 2017

published in

1 reference

25 August 2017

volume

55

1 reference

25 August 2017

issue

10

1 reference

25 August 2017

page(s)

1441-1453

1 reference

Inflammatory Bowel Disease

25 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201100139

Mechanisms of Disease: pathogenesis of Crohn's disease and ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201100139

Therapeutic manipulation of the enteric microflora in inflammatory bowel diseases: antibiotics, probiotics, and prebiotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201100139

Genes and molecules of lactobacilli supporting probiotic action

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201100139

Role of probiotic therapy in IBD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201100139

Insights from advances in research of chemically induced experimental models of human inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201100139

Experimental models of inflammatory bowel disease reveal innate, adaptive, and regulatory mechanisms of host dialogue with the microbiota

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201100139

Acute colitis induced by dextran sulfate sodium progresses to chronicity in C57BL/6 but not in BALB/c mice: correlation between symptoms and inflammation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201100139

Maintaining remission of ulcerative colitis with the probiotic Escherichia coli Nissle 1917 is as effective as with standard mesalazine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201100139

Non-pathogenic Escherichia coli versus mesalazine for the treatment of ulcerative colitis: a randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201100139

Nonpathogenic Escherichia coli strain Nissle1917 prevents murine acute and chronic colitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201100139

Escherichia coli strain Nissle 1917 ameliorates experimental colitis via toll-like receptor 2- and toll-like receptor 4-dependent pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201100139

Oral administration of probiotic bacteria (E. coli Nissle, E. coli O83, Lactobacillus casei) influences the severity of dextran sodium sulfate-induced colitis in BALB/c mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201100139

Probiotic Escherichia coli Nissle 1917 inhibits leaky gut by enhancing mucosal integrity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201100139

VSL#3 probiotic mixture: a review of its use in chronic inflammatory bowel diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201100139

Toll-like receptor 9 signaling mediates the anti-inflammatory effects of probiotics in murine experimental colitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201100139

Discussion on toll-like receptor 9 signaling mediates the anti-inflammatory effects of probiotics in murine experimental colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201100139

Probiotic mixture VSL#3 protects the epithelial barrier by maintaining tight junction protein expression and preventing apoptosis in a murine model of colitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201100139

Probiotic administration alters the gut flora and attenuates colitis in mice administered dextran sodium sulfate.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201100139

Effects of Lactobacillus salivarius 433118 on intestinal inflammation, immunity status and in vitro colon function in two mouse models of inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201100139

Impact of lipoteichoic acid modification on the performance of the probiotic Lactobacillus rhamnosus GG in experimental colitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201100139

Comparison of the immunomodulatory properties of three probiotic strains of Lactobacilli using complex culture systems: prediction for in vivo efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201100139

Regulation of induced colonic inflammation by Lactobacillus acidophilus deficient in lipoteichoic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201100139

Antibodies to interleukin 12 abrogate established experimental colitis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201100139

Probiotics ameliorate recurrent Th1-mediated murine colitis by inducing IL-10 and IL-10-dependent TGF-beta-bearing regulatory cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201100139

Prevention of TNBS-induced colitis by different Lactobacillus and Bifidobacterium strains is associated with an expansion of gammadeltaT and regulatory T cells of intestinal intraepithelial lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201100139

Selecting lactic acid bacteria for their safety and functionality by use of a mouse colitis model

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201100139

Correlation between in vitro and in vivo immunomodulatory properties of lactic acid bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201100139

Lactobacillus fermentum ACA-DC 179 displays probiotic potential in vitro and protects against trinitrobenzene sulfonic acid (TNBS)-induced colitis and Salmonella infection in murine models

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201100139

Enhanced antiinflammatory capacity of a Lactobacillus plantarum mutant synthesizing modified teichoic acids

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201100139

Bacillus polyfermenticus ameliorates colonic inflammation by promoting cytoprotective effects in colitic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201100139

Selection of bifidobacteria based on adhesion and anti-inflammatory capacity in vitro for amelioration of murine colitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201100139

Lactobacillus fermentum CECT 5716 prevents and reverts intestinal damage on TNBS-induced colitis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201100139

Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201100139

Reduced diversity of faecal microbiota in Crohn's disease revealed by a metagenomic approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201100139

T helper cell 1-type CD4+ T cells, but not B cells, mediate colitis in interleukin 10-deficient mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201100139

Enterocolitis and colon cancer in interleukin-10-deficient mice are associated with aberrant cytokine production and CD4(+) TH1-like responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201100139

Posttranslational inhibition of proinflammatory chemokine secretion in intestinal epithelial cells: implications for specific IBD indications

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201100139

Balancing inflammatory, lipid, and xenobiotic signaling pathways by VSL#3, a biotherapeutic agent, in the treatment of inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201100139

VSL#3 probiotic upregulates intestinal mucosal alkaline sphingomyelinase and reduces inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201100139

Lactobacillus plantarum prevents the development of colitis in IL-10-deficient mouse by reducing the intestinal permeability

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201100139

Lactobacillus plantarum prevents the upregulation of adhesion molecule expression in an experimental colitis model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201100139

Lactobacillus plantarum consumption increases PepT1-mediated amino acid absorption by enhancing protein kinase C activity in spontaneously colitic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201100139

Lactobacillus plantarum ameliorates colonic epithelial barrier dysfunction by modulating the apical junctional complex and PepT1 in IL-10 knockout mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201100139

Double blind, placebo controlled trial of two probiotic strains in interleukin 10 knockout mice and mechanistic link with cytokine balance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201100139

Is the mucosal route of administration essential for probiotic function? Subcutaneous administration is associated with attenuation of murine colitis and arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201100139

Probiotic Lactobacillus spp. diminish Helicobacter hepaticus-induced inflammatory bowel disease in interleukin-10-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201100139

Mouse models for the study of Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201100139

Bifidobacterium animalis subsp. lactis fermented milk product reduces inflammation by altering a niche for colitogenic microbes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201100139

Colitic scid mice fed Lactobacillus spp. show an ameliorated gut histopathology and an altered cytokine profile by local T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201100139

Preinoculation with the probiotic Lactobacillus acidophilus early in life effectively inhibits murine Citrobacter rodentium colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201100139

A three-dimensional coculture of enterocytes, monocytes and dendritic cells to model inflamed intestinal mucosa in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201100139

Is there any place for alimentary probiotics, prebiotics or synbiotics, for patients with inflammatory bowel disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201100139

Mechanisms of probiotic action: Implications for therapeutic applications in inflammatory bowel diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201100139

Meta-analysis: the effect and adverse events of Lactobacilli versus placebo in maintenance therapy for Crohn disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201100139

Initial sequencing and comparative analysis of the mouse genome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201100139

Microbial ecology: human gut microbes associated with obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201100139

Probiotic bacteria are antagonistic to Salmonella enterica and Campylobacter jejuni and influence host lymphocyte responses in human microbiota-associated immunodeficient and immunocompetent mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201100139

Targeting the human microbiome with antibiotics, probiotics, and prebiotics: gastroenterology enters the metagenomics era

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201100139

Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201100139

A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201100139

Commensal bacteria, traditional and opportunistic pathogens, dysbiosis and bacterial killing in inflammatory bowel diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201100139

Probiotics promote gut health through stimulation of epithelial innate immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201100139

Lactobacillus GG: bacteriology and clinical applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201100139

Role of lipoteichoic acid in infection and inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201100139

Host interactions of probiotic bacterial surface molecules: comparison with commensals and pathogens

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201100139

Beneficial effect of auto-aggregating Lactobacillus crispatus on experimentally induced colitis in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201100139

Live Lactobacillus rhamnosus [corrected] is essential for the inhibitory effect on tumor necrosis factor alpha-induced interleukin-8 expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201100139

Lactobacillus rhamnosus alleviates intestinal barrier dysfunction in part by increasing expression of zonula occludens-1 and myosin light-chain kinase in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201100139

Regulation of inflammatory responses by gut microbiota and chemoattractant receptor GPR43

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201100139

S layer protein A of Lactobacillus acidophilus NCFM regulates immature dendritic cell and T cell functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201100139

Soluble proteins produced by probiotic bacteria regulate intestinal epithelial cell survival and growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201100139

Anti-inflammatory effects of Lactobacillus casei BL23 producing or not a manganese-dependant catalase on DSS-induced colitis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201100139

Therapeutic effects of four strains of probiotics on experimental colitis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201100139

In vitro and in vivo effects of the probiotic Escherichia coli strain M-17: immunomodulation and attenuation of murine colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201100139

1H NMR-based metabonomic assessment of probiotic effects in a colitis mouse model

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201100139

Effect of oral administration of Butyrivibrio fibrisolvens MDT-1 on experimental enterocolitis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201100139

Protective effects of Lactobacillus rhamnosus [corrected] and Bifidobacterium infantis in murine models for colitis do not involve the vagus nerve

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201100139

Recommendations for improved use of the murine TNBS-induced colitis model in evaluating anti-inflammatory properties of lactic acid bacteria: technical and microbiological aspects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201100139

Probiotic properties of non-conventional lactic acid bacteria: immunomodulation by Oenococcus oeni.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201100139

Probiotic yeasts: anti-inflammatory potential of various non-pathogenic strains in experimental colitis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201100139

Immunomodulatory effects of probiotic bacteria DNA: IL-1 and IL-10 response in human peripheral blood mononuclear cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201100139

Specificities of the fecal microbiota in inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201100139

21 January 2018

Identifiers

DOI

10.1002/MNFR.201100139

1 reference

25 August 2017

1 reference